Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis

Clinical and molecular hepatology

Volumn 20, Issue 4, 2014, Pages 384-391

  Chung, Jung W ha ^a   Kim, Gi H yun ^a   Lee, Jong H o ^a   Ok, Kyeong S am ^a   Jang, Eun S un ^a   Jeong, Sook Hyang ^a   Kim, Jin Wook ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Liver cirrhosis; Portal vein; Propensity score; Venous thrombosis; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; WARFARIN;

AGED; CLINICAL TRIAL; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PATHOLOGY; PORTAL VEIN; PROPENSITY SCORE; SEVERITY OF ILLNESS INDEX; VENOUS THROMBOSIS;

AGED; ANTICOAGULANTS; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PORTAL VEIN; PROPENSITY SCORE; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS; WARFARIN;

EID: 84965095178     PISSN: None     EISSN: 2287285X     Source Type: Journal    
DOI: 10.3350/cmh.2014.20.4.384     Document Type: Article

References (0)